PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 260 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $233,000 | -13.7% | 4,159 | -6.4% | 0.03% | -3.1% |
Q2 2021 | $270,000 | -17.9% | 4,444 | -5.2% | 0.03% | -15.8% |
Q1 2021 | $329,000 | -15.6% | 4,690 | -28.1% | 0.04% | -13.6% |
Q4 2020 | $390,000 | -3.5% | 6,525 | -7.4% | 0.04% | -10.2% |
Q3 2020 | $404,000 | +5.2% | 7,047 | -3.7% | 0.05% | +2.1% |
Q2 2020 | $384,000 | +83.7% | 7,320 | +17.7% | 0.05% | +54.8% |
Q1 2020 | $209,000 | -36.1% | 6,219 | -13.8% | 0.03% | -18.4% |
Q4 2019 | $327,000 | +16.4% | 7,213 | -2.3% | 0.04% | +26.7% |
Q3 2019 | $281,000 | +44.8% | 7,386 | +65.5% | 0.03% | +50.0% |
Q2 2019 | $194,000 | +36.6% | 4,463 | +19.5% | 0.02% | -39.4% |
Q1 2019 | $142,000 | -71.2% | 3,735 | -59.9% | 0.03% | -45.0% |
Q1 2016 | $493,000 | -37.7% | 9,303 | -9.7% | 0.06% | -25.9% |
Q4 2015 | $791,000 | +100.3% | 10,303 | +130.9% | 0.08% | +145.5% |
Q4 2014 | $395,000 | -73.4% | 4,463 | -70.8% | 0.03% | -72.5% |
Q3 2014 | $1,484,000 | -16.2% | 15,308 | -20.6% | 0.12% | -14.9% |
Q2 2014 | $1,771,000 | +71.6% | 19,288 | +30.8% | 0.14% | +88.0% |
Q1 2014 | $1,032,000 | +127.3% | 14,750 | +86.7% | 0.08% | +108.3% |
Q4 2013 | $454,000 | +15.2% | 7,900 | -3.7% | 0.04% | +12.5% |
Q3 2013 | $394,000 | – | 8,200 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |